Tayem Yasin I, Qubaja Marwan M, Shraim Riyad K, Taha Omar B, Abu Shkheidem Imadeddin A, Ibrahim Murad A
Al-Quds University Medical School, Beit Hanina, Jerusalem, Palestine;
Sultan Qaboos Univ Med J. 2013 Nov;13(4):567-73. doi: 10.12816/0003317. Epub 2013 Nov 8.
We aimed to reliably describe the pattern of outpatient prescription of non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics (ATBs) at a central hospital in the West Bank, Palestine.
This was a retrospective, cross-sectional study investigating a cohort of 2,208 prescriptions ordered by outpatient clinics and the emergency room over one year in Beit Jala Hospital in Bethlehem, West Bank. The orders were analysed for the rate and types of NSAIDs and ATBs utilised, and the appropriateness of these drugs to the diagnosis.
Of the total prescriptions, 410 contained NSAIDs (18.6%), including diclofenac (40.2%), low dose aspirin (23.9%), ibuprofen (17.8%) and indomethacin (15.1%). A minority of these prescriptions contained a combination of these agents (2.5%). Only one prescription contained cyclooxyeganse-2 inhibitors (0.2%). The appropriateness of NSAID use to the diagnosis was as follows: appropriate (58.3%), inappropriate (14.4%) and difficult to tell (27.3%). The rate of ATB use was 30.3% (669 prescriptions). The ATBs prescribed were amoxicillin (23.3%), augmentin (14.3%), quinolones (12.7%), first and second generation cephalosporins (9.4% and 12.7%, respectively) and macrolides (7.2%). ATB combinations were identified in 9.4%, with the most common being second-generation cephalopsorins and metronidazole (4.3%). Regarding the appropriateness of prescribing ATBs according to the diagnosis, it was appropriate in 44.8%, inappropriate in 20.6% and difficult to tell in 34.6% of the prescriptions.
These findings revealed a relatively large number and inappropriate utilisation of ATBs and NSAIDs. An interventional programme needs to be adopted to reinforce physicians' knowledge of the rational prescription of these agents.
我们旨在可靠地描述巴勒斯坦约旦河西岸一家中心医院非甾体抗炎药(NSAIDs)和抗生素(ATBs)的门诊处方模式。
这是一项回顾性横断面研究,调查了约旦河西岸伯利恒拜特贾拉医院门诊诊所和急诊室在一年时间内开出的2208份处方。对这些处方中NSAIDs和ATBs的使用比例和类型,以及这些药物与诊断的适配性进行分析。
在所有处方中,410份含有NSAIDs(18.6%),其中双氯芬酸(40.2%)、低剂量阿司匹林(23.9%)、布洛芬(17.8%)和吲哚美辛(15.1%)。这些处方中少数含有这些药物的组合(2.5%)。只有一份处方含有环氧化酶-2抑制剂(0.2%)。NSAIDs使用与诊断的适配情况如下:合适(58.3%)、不合适(14.4%)、难以判断(27.3%)。ATB使用率为30.3%(669份处方)。所开的ATBs为阿莫西林(23.3%)、奥格门汀(14.3%)、喹诺酮类(12.7%)、第一代和第二代头孢菌素(分别为9.4%和12.7%)以及大环内酯类(7.2%)。9.4%的处方中存在ATB组合,最常见的是第二代头孢菌素和甲硝唑(4.3%)。关于根据诊断开具ATBs的适配性,44.8%的处方合适,20.6%不合适,34.6%难以判断。
这些发现揭示了ATBs和NSAIDs的使用数量相对较多且存在不合理使用的情况。需要采取一项干预计划来加强医生对这些药物合理处方的认识。